Business Description
Hoth Therapeutics Inc
NAICS : 325411
SIC : 2833
ISIN : US44148G2049
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 168.95 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 46.5 | |||||
3-Year EPS without NRI Growth Rate | 46.2 | |||||
3-Year FCF Growth Rate | 42 | |||||
3-Year Book Growth Rate | -38.3 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.12 | |||||
9-Day RSI | 36.86 | |||||
14-Day RSI | 40.04 | |||||
6-1 Month Momentum % | 8.57 | |||||
12-1 Month Momentum % | -20 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 13.89 | |||||
Quick Ratio | 13.89 | |||||
Cash Ratio | 13.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -100.7 | |||||
Shareholder Yield % | -197.81 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -84.8 | |||||
ROA % | -72.99 | |||||
ROIC % | -15203.56 | |||||
ROC (Joel Greenblatt) % | -13987.27 | |||||
ROCE % | -81.78 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.57 | |||||
Price-to-Tangible-Book | 0.57 | |||||
EV-to-EBIT | 0.46 | |||||
EV-to-EBITDA | 0.46 | |||||
EV-to-FCF | 0.42 | |||||
Price-to-Net-Current-Asset-Value | 0.58 | |||||
Price-to-Net-Cash | 0.59 | |||||
Earnings Yield (Greenblatt) % | 217.39 | |||||
FCF Yield % | -148.98 |